VivaQuant is a digital health care company providing remote cardiac monitoring services to clinics and hospitals under the Rhythm Express brand. The company's highly differentiated mobile cardiac telemetry (MCT) wearable, the RX-1 mini, enables near real-time observation of a patient's heart rhythm and can be comfortably worn for up to 30 days. The mini was designed from the ground up to provide the trifecta of wearables - a device that is easy to wear, easy to use, and provides accurate diagnostic data. The mini contains proprietary noise cancelling algorithms that result in high-clarity ECGs, and our proprietary wavelet analytics provide near-perfect identification of cardiac arrhythmias and facilitate fast diagnosis. We provide 24/7/365 oversight of incoming patient data from the mini, where millions of heart beats are translated into actionable information that physicians can use as an aid in diagnosis and establishing life-saving care plans for patients.

Go to Rhythm Express Website

VivaQuant, Inc. Named Finalist for 2021 Tekne Awards

October 26, 2021   Read more >

VivaQuant Introduces Smallest One-Piece Mobile Cardiac Telemetry Device

January 28th, 2021   Read more >

Minneapolis Star Tribune: VivaQuant is making an intriguing bet on equity crowdfunding

May 19th, 2019   Read more >

VivaQuant Receives FDA 510k Clearance for its RX-1 Rhythm Express Arrhythmia Device

April 30th, 2019   Read more >

VivaQuant inks collaboration with FDA to improve accuracy of drug cardiac safety assessment

October 2018   Read more >

VivaQuant technology shows promise for improving drug safety assessment accuracy

June 2018   Read more >

Meet VivaQuant at the Society of Toxicology 2018 in San Antonio

March 12-14, 2018   Read more >

LIVE WEBINAR: Improving Preclinical and Clinical Regulatory Submissions Through Enhanced ECG Interval and Arrhythmia Assessment

March 1st, 2018   Read more >

VivaQuant Rhythm Express software demonstrates improved accuracy of cardiac safety assessment markers

December 2017   Read more >

VivaQuant and DSI Announce Agreement

September 2017   Read more >

ECG Services

VivaQuant provides continuous beat-to-beat analysis services for ambulatory ECGs from preclinical and clinical research studies. Services include restitution analysis, predictive modeling, and complex statistics.

More information >

ECG Analysis Software

VivaQuant AE-1010 software for arrhythmia and beat-to-beat interval analysis of preclinical ECGs is fast, accurate, easy to learn, and easy to validate - saving you time and money. Process a 24-hour recording in 10-20 seconds.

More information >

Technology Licensing

VivaQuant licenses MDSP technology for select fields of use and is available for both Windows PC platforms and ultra-low-power ARM Cortex embedded platforms for heart rate measurement and arrhythmia detection.

More information >

© 2020 VivaQuant, Inc. | Sitemap